http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 09 Jun 2026 16:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+PRYGOCKI+MARK+A+SR/26623857.html si-local-file:///var/storage/secattach/20260609/26623857.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+PRYGOCKI+MARK+A+SR/26623857.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+PRYGOCKI+MARK+A+SR/26623857.html si-local-file:///var/storage/secattach/20260609/26623857.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+PRYGOCKI+MARK+A+SR/26623857.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rosenberg+Noah+L./26623858.html si-local-file:///var/storage/secattach/20260609/26623858.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rosenberg+Noah+L./26623858.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rosenberg+Noah+L./26623858.html si-local-file:///var/storage/secattach/20260609/26623858.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rosenberg+Noah+L./26623858.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Eichenfield+Lawrence/26623861.html si-local-file:///var/storage/secattach/20260609/26623861.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Eichenfield+Lawrence/26623861.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Eichenfield+Lawrence/26623861.html si-local-file:///var/storage/secattach/20260609/26623861.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Eichenfield+Lawrence/26623861.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Nguyen+Diem/26623866.html si-local-file:///var/storage/secattach/20260609/26623866.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Nguyen+Diem/26623866.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Nguyen+Diem/26623866.html si-local-file:///var/storage/secattach/20260609/26623866.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Nguyen+Diem/26623866.html Tue, 09 Jun 2026 16:16:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Corcoran+Gavin/26623836.html si-local-file:///var/storage/secattach/20260609/26623836.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Corcoran+Gavin/26623836.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Corcoran+Gavin/26623836.html si-local-file:///var/storage/secattach/20260609/26623836.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Corcoran+Gavin/26623836.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Zawitz+David/26623838.html si-local-file:///var/storage/secattach/20260609/26623838.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Zawitz+David/26623838.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Zawitz+David/26623838.html si-local-file:///var/storage/secattach/20260609/26623838.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Zawitz+David/26623838.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rieger+Jayson/26623847.html si-local-file:///var/storage/secattach/20260609/26623847.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rieger+Jayson/26623847.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rieger+Jayson/26623847.html si-local-file:///var/storage/secattach/20260609/26623847.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05++Filed+by%3A+Rieger+Jayson/26623847.html Tue, 09 Jun 2026 16:15:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05/26623637.html si-local-file:///var/storage/secattach/20260609/26623637.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05/26623637.html Tue, 09 Jun 2026 16:06:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05/26623637.html si-local-file:///var/storage/secattach/20260609/26623637.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Verrica+Pharmaceuticals+++For%3A+Jun+05/26623637.html Tue, 09 Jun 2026 16:06:00 -0400 O.38262917 VRCA http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+Jefferies+Global+Healthcare+Conference/26561496.html <p align="left">WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the Jefferies Global Healthcare Conference.</p> <p><strong>Jefferies Global Healthcare Conference, June 2-4, 2026</strong><br /><strong>Event details:</strong><br />Date: Thursday, June 4, 2026<br />Time: 11:05am ET<br />Location: New York</p> <p>Participants may access a live webcast of the event by clicking the link <a href="https://www.globenewswire.com/Tracker?data=8vN8kk3PmJpNgKDdhFX1yaD3WdwELOUKzLvGrH1Oh1Jp-OtpOBcdoVBccmtX1DznePmCa85yQBJo3m06N6WGjiaRyWlv7yiW2ihVxXdyoCfhVYvj3sAqhc0YchzMTUolJ699SEEeUtX8wkh7fuXt4urBpAPINNpnM3ib0yrWZHKw7LJ1SCIPsLqrXCOH8hCH" rel="nofollow" target="_blank">here</a>.</p> <p>The webcast can http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+Jefferies+Global+Healthcare+Conference/26561496.html Thu, 28 May 2026 08:05:00 -0400 VRCA http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+Jefferies+Global+Healthcare+Conference/26561496.html <p align="left">WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the Jefferies Global Healthcare Conference.</p> <p><strong>Jefferies Global Healthcare Conference, June 2-4, 2026</strong><br /><strong>Event details:</strong><br />Date: Thursday, June 4, 2026<br />Time: 11:05am ET<br />Location: New York</p> <p>Participants may access a live webcast of the event by clicking the link <a href="https://www.globenewswire.com/Tracker?data=8vN8kk3PmJpNgKDdhFX1yaD3WdwELOUKzLvGrH1Oh1Jp-OtpOBcdoVBccmtX1DznePmCa85yQBJo3m06N6WGjiaRyWlv7yiW2ihVxXdyoCfhVYvj3sAqhc0YchzMTUolJ699SEEeUtX8wkh7fuXt4urBpAPINNpnM3ib0yrWZHKw7LJ1SCIPsLqrXCOH8hCH" rel="nofollow" target="_blank">here</a>.</p> <p>The webcast can http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+Jefferies+Global+Healthcare+Conference/26561496.html Thu, 28 May 2026 08:05:00 -0400 VRCA http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Assumes+Verrica+Pharmaceuticals+%28VRCA%29+at+Buy/26545358.html <p>H.C. Wainwright analyst Raghuram Selvaraju assumes coverage on Verrica Pharmaceuticals (NASDAQ: VRCA) with a Buy rating and a price target of $12.00.</p><p>For an analyst ratings summary and ratings history on Verrica Pharmaceuticals <a href="http://www.streetinsider.com/rating_history.php?q=VRCA">click here</a>. For more ratings news on Verrica Pharmaceuticals <a href="http://www.streetinsider.com/stock_lookup_news.php?q=VRCA&amp;type=analyst">click here</a>.</p><p>Shares of Verrica Pharmaceuticals closed at $6.06 yesterday.</p> http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Assumes+Verrica+Pharmaceuticals+%28VRCA%29+at+Buy/26545358.html Tue, 26 May 2026 06:15:30 -0400 VRCA http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html <p>WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ.</p> <p><strong>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, May 19, 2026</strong><br/><strong>Event details:</strong><br/>Date: Tuesday, May 19, 2026<br/>Time: 1:30pm ET<br/>Location: NASDAQ</p> <p>Participants may access a live webcast of the event by clicking the link <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YoNKJXW1A_K2-ai00FVJKWjhpnxRgOeAPb-JEs4Q5oV8oDkfJQZ5m2rJOLGoasDI4-Afv2W2ewgreftKalsS8LMsfkgfZK3dWqwyzL1cY-fz1hkIvj4tqm8C2CdsoSU6Ol7agvQDE4EOAJEty5ROmQ==" rel="nofollow" http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html Wed, 13 May 2026 08:00:00 -0400 O.38262917 VRCA http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html <p>WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ.</p> <p><strong>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, May 19, 2026</strong><br/><strong>Event details:</strong><br/>Date: Tuesday, May 19, 2026<br/>Time: 1:30pm ET<br/>Location: NASDAQ</p> <p>Participants may access a live webcast of the event by clicking the link <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YoNKJXW1A_K2-ai00FVJKWjhpnxRgOeAPb-JEs4Q5oV8oDkfJQZ5m2rJOLGoasDI4-Afv2W2ewgreftKalsS8LMsfkgfZK3dWqwyzL1cY-fz1hkIvj4tqm8C2CdsoSU6Ol7agvQDE4EOAJEty5ROmQ==" rel="nofollow" http://www.streetinsider.com/Press+Releases/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html Wed, 13 May 2026 08:00:00 -0400 O.38262917 VRCA http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html <p>WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ.</p> <p><strong>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, May 19, 2026</strong><br/><strong>Event details:</strong><br/>Date: Tuesday, May 19, 2026<br/>Time: 1:30pm ET<br/>Location: NASDAQ</p> <p>Participants may access a live webcast of the event by clicking the link <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YoNKJXW1A_K2-ai00FVJKWjhpnxRgOeAPb-JEs4Q5oV8oDkfJQZ5m2rJOLGoasDI4-Afv2W2ewgreftKalsS8LMsfkgfZK3dWqwyzL1cY-fz1hkIvj4tqm8C2CdsoSU6Ol7agvQDE4EOAJEty5ROmQ==" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html Wed, 13 May 2026 08:00:00 -0400 O.38262917 VRCA http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html <p>WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ.</p> <p><strong>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, May 19, 2026</strong><br/><strong>Event details:</strong><br/>Date: Tuesday, May 19, 2026<br/>Time: 1:30pm ET<br/>Location: NASDAQ</p> <p>Participants may access a live webcast of the event by clicking the link <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YoNKJXW1A_K2-ai00FVJKWjhpnxRgOeAPb-JEs4Q5oV8oDkfJQZ5m2rJOLGoasDI4-Afv2W2ewgreftKalsS8LMsfkgfZK3dWqwyzL1cY-fz1hkIvj4tqm8C2CdsoSU6Ol7agvQDE4EOAJEty5ROmQ==" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/Verrica+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+4th+Annual+BioConnect+Investor+Conference+at+NASDAQ/26482028.html Wed, 13 May 2026 08:00:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Verrica+Pharmaceuticals++++++++++++++/26479542.html si-local-file:///var/storage/secattach/20260512/26479542.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Verrica+Pharmaceuticals++++++++++++++/26479542.html Tue, 12 May 2026 17:30:00 -0400 O.38262917 VRCA http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Verrica+Pharmaceuticals++++++++++++++/26479542.html si-local-file:///var/storage/secattach/20260512/26479542.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Verrica+Pharmaceuticals++++++++++++++/26479542.html Tue, 12 May 2026 17:30:00 -0400 O.38262917 VRCA